Inaktiver Wert

Andere Sprachen Oxford BioMedica plc London S.E.

Aktien

FTSE 100 as investors look to Fed rate decision	29.04.
Oxford Biomedica : Preliminary results for the year ended 31 December 2023 29 April 2024	29.04.
Oxford BioMedica bullish; Petrofac slumps	29.04.
Earnings Flash (OXB.L) OXFORD BIOMEDICA Reports FY23 Revenue GBP89.5M	29.04.
Oxford Biomedica plc Reiterates Earnings Guidance for the Year 2024	29.04.
Oxford Biomedica plc Reports Earnings Results for the Full Year Ended December 31, 2023	29.04.
HSBC likes Haleon, cuts Flutter to 'hold'	18.04.
EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake	20.03.
Oxford Biomedica Secures New Deal, Expands Existing Agreements for Clinical Programs	20.03.
Oxford Biomedica plc Announces Board Changes	11.03.
EARNINGS AND TRADING: Harland & Wolff wins major Falklands contract	05.03.
Update to Medium-Term Financial Guidance and 2023 Trading and Notice of Preliminary Results	05.03.
Oxford Biomedica plc Provides Earnings Guidance for the Year Ended December 31, 2023 and for the Fiscal Year 2024	05.03.
Barclays cuts Bank of Ireland to 'equal weight'	05.03.
EnSilica hires new chief financial officer from Oxford Biomedica	05.02.
EnSilica Appoints Oxford Biomedica Executive as CFO	05.02.
Oxford Biomedica Completes EUR15 Million ABL Europe Acquisition	29.01.
Institut Merieux ups stake in Oxford BioMedica toward 10%	29.01.
Oxford Biomedica completes acquisition of ABL Europe	29.01.
Oxford Biomedica plc completed the acquisition of additional 3.2% stake in ABL EUROPE S.A.S. from TSGH ?6.1 million	29.01.

Keine Ergebnisse zu dieser Suche